Year Founded
1981
Ownership
Private
Employees
~100
Stage
Commercial
Modalities
Hycor Biomedical General Information
Manufacturer of in vitro diagnostic products for allergy and autoimmune testing, with focus on IgE testing using their NOVEOS system that requires only 4 μL of sample per allergen
Drug Pipeline
No pipeline data available
Key Partnerships
Hycor Biomedical Funding
Deal Type | Date | Amount | Status | Stage |
---|
To view Hycor Biomedical's complete valuation and funding history, request access »
Hycor Biomedical Investors
Linden Capital Partners
Investor Type: Venture Capital
Holding: Minority
Ping An Venture Capital
Investor Type: Venture Capital
Holding: Minority
Paycheck Protection Program
Investor Type: Venture Capital
Holding: Minority
You're viewing 3 of 5 investors. Get the full list »